Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy
|
|
- Rosanna Gilmore
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLES: EARLY PREGNANCY Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy Bruce S. Shapiro, M.D., Ph.D., a,b Said T. Daneshmand, M.D., a,b Laura De Leon, M.D., b Forest C. Garner, M.Sc., a,b Martha Aguirre, Ph.D., a and Cynthia Hudson, M.S. a a Fertility Center of Las Vegas and b Department of Obstetrics and Gynecology, University of Nevada School of Medicine, Las Vegas, Nevada Objective: To compare the incidence of ectopic pregnancy (EP) after fresh ET and thawed ET. Design: Retrospective cohort study. Setting: Private fertility center. Patient(s): This retrospective study included 2,150 blastocyst transfers, including all 1,460 fresh autologous blastocyst transfers and all 690 transfers of autologous blastocysts derived from post-thaw extended culture of thawed bipronuclear oocytes in the 8-year study period Intervention(s): None. Main Outcome Measure(s): Visualized EP and treated persistent pregnancy of unknown location. Result(s): The rate of visualized EP was 1.5% in pregnancies in fresh autologous cycles, which was significantly more than the rate of 0 with autologous post-thaw extended culture. The rates of treated persistent pregnancy of unknown location were 2.5% and 0.3% in these two groups, respectively, a difference that was also statistically significant (relative risk 7.3, 95% confidence interval ). Conclusion(s): Relative to fresh transfer, thawed ET was associated with significantly reduced incidence of EP. These findings are consistent with ovarian stimulation increasing the risk of EP. (Fertil Steril Ò 2012;98: Ó2012 by American Society for Reproductive Medicine.) Key Words: Ectopic pregnancy, assisted reproduction, ovarian stimulation, embryo cryopreservation Discuss: You can discuss this article with its authors and with other ASRM members at fertstertforum.com/shapirobs-embryo-cryopreservation-ectopic-pregnancy/ Use your smartphone to scan this QR code and connect to the discussion forum for this article now.* * Download a free QR code scanner by searching for QR scanner in your smartphone s app store or app marketplace. Ectopic pregnancy (EP) is approximately twice as frequent in pregnancies from assisted reproductive technologies (ART) as in spontaneous pregnancies (1). Reported rates of tubal EPs in ART range from 2% 5% (2, 3). Multiple hypotheses have been offered to explain the increased risk of EP in ART. These include specific attributes of ART patients, such as tubal Received June 19, 2012; revised July 17, 2012; accepted July 25, 2012; published online August 25, B.S.S. reports research grants from Merck Sharp & Dohme Inc., Ferring Pharmaceuticals Inc., Watson Pharmaceuticals Inc., and payment for lectures from Merck Sharp & Dohme Inc. (not related to this work). He also reports a consultancy with Cooper Surgical (not related to this work. S.T.D. reports research grants from Merck Sharp & Dohme Inc., Ferring Pharmaceuticals Inc., and Watson Pharmaceuticals Inc. (not related to this work). L.D.L. has nothing to disclose. F.C.G. reports research grants from Merck Sharp & Dohme Inc., Ferring Pharmaceuticals Inc., and Watson Pharmaceuticals Inc. (not related to this work). M.A. reports research grants from Merck Sharp & Dohme Inc., Ferring Pharmaceuticals Inc., and Watson Pharmaceuticals Inc. (not related to this work). C.H. reports research grants from Merck Sharp & Dohme Inc., Ferring Pharmaceuticals Inc., and Watson Pharmaceuticals Inc. (not related to this work). Reprint requests: Bruce S. Shapiro, M.D., Ph.D., Fertility Center of Las Vegas, 8851 West Sahara Avenue, Las Vegas, NV ( bsshapiro@aol.com). Fertility and Sterility Vol. 98, No. 6, December /$36.00 Copyright 2012 American Society for Reproductive Medicine, Published by Elsevier Inc. disease and other infertility diagnoses (3 5). Other hypothesized causes include the use of ovarian stimulation (6), resulting in increased uterine contractions secondary to elevated E 2 levels (7, 8), or ciliary dysfunction secondary to elevated P levels (9). Tobacco use has also been correlated with EP after IVF (10). A large study of ART registry data from US clinics in found the rates of EP were reduced in fresh oocyte donation cycles, but not in cycles of frozen-thawed ET, when compared with fresh autologous cycles, and generally concluded that embryos with high implantation potential were protective against EP (5). That study also associated increased EP 1490 VOL. 98 NO. 6 / DECEMBER 2012
2 Fertility and Sterility incidence with diagnoses of tubal factor, uterine factor, endometriosis, diminished ovarian reserve, and unexplained infertility, when compared with a reference group with male factor diagnosis. A subsequent registry study using data from 2008 compared single ETs and associated frozen-thawed ET with decreased risk of EP when compared with fresh autologous transfer, concluding that a negative effect of ovarian stimulation on endometrial receptivity was reflected in increased EP rates in fresh autologous cycles (11). These two registry studies failed to reach consensus on whether EP incidence was reduced in frozen-thawed ET cycles. Autologous blastocysts derived from post-thaw extended culture (PTEC) of thawed bipronuclear oocytes have been found to have implantation potential comparable with fresh blastocysts transferred in oocyte donation cycles (12). Two prospective trials found implantation rates of 67% and 71% in autologous PTEC cycles (13, 14). This technique has been used for other purposes, including reducing ovarian hyperstimulation syndrome (OHSS) risk (15, 16). The current study compares the rate of EP in autologous PTEC cycles to that after fresh autologous blastocyst transfer to determine whether PTEC is associated with different EP risk than fresh autologous IVF. This might help to resolve the lack of consensus on whether EP incidence may be reduced through frozen-thawed ET. MATERIALS AND METHODS This study included all fresh autologous blastocyst transfers and all transfers of blastocysts derived from thawed bipronuclear oocytes in the 8-year study period ending December 31, Cycles using gestational carriers or donated oocytes were excluded. Patients underwent ovarian stimulation with gonadotropins (FSH or hmg, typically in combination). Pituitary suppression was routinely achieved with GnRH antagonist. When at least half of those follicles with a mean diameter R12 mm had reached 16 mm in mean diameter, the patient was given hcg (typically 2,500 10,000 IU) or GnRH agonist (GnRH-a; 4 mg leuprolide acetate [LA]), or both in combination (4 mg LA with concomitant hcg, typically IU per kg of body weight) for final oocyte maturation, followed approximately 35 hours later by oocyte retrieval. Oocytes were inseminated only by intracytoplasmic sperm injection (ICSI), and resulting embryos were cultured to the blastocyst stage in sequential media, as described previously (13). Blastocysts were transferred by ultrasound guidance on day 5, 6, or, rarely, on day 7 of embryo development, depending on the day of blastocyst expansion. The ICSI and blastocyst transfer were standards of care for all patients at this center throughout the study period. Bipronuclear oocytes were cryopreserved and thawed using conventional slow freezing, as described previously (13). Patients were offered the option of cohort cryopreservation based on premature luteinization, history of implantation failure after fresh transfer, or as participants in randomized trials (13, 14). Before transfer, patients received E 2 supplements (oral pills [Estrace Warner Chilcott] 6.0 mg daily and patches as needed) starting days before thaw. Daily P injections (usually 100 mg) were started the day before thaw. After thaw, embryo culture and blastocyst transfer were as described for fresh transfers. Before transfer, the diameter of each blastocyst was measured along its longest axis through an ocular micrometer. Inner cell masses (ICMs) were measured along their longest axis and along its widest perpendicular, and these two measures were multiplied to estimate the cross-sectional area. The trophectoderm was measured by counting cells along an equator in one plane of focus. Pregnancy was established through subsequent serially increasing serum titers of hcg measured to day 10 after blastocyst transfer, with subsequent measurements every 2 4 days in pregnant patients until the first ultrasound examination, and approximately weekly thereafter. Pregnant patients typically received three to four serial ultrasound examinations commencing at 5 6 weeks' gestation to confirm intrauterine gestation, examine the adnexa, and follow subsequent development. Those with abnormally increasing hcg serum titers were considered suggestive of potential EP. These received more frequent ultrasound examinations in the 5 6 week time frame, often at 48-hour intervals, until the location of the pregnancy was visualized or hcg titers began to resolve. Luteal support in all cycles included E 2 and P supplements sufficient to sustain serum levels of 200 pg/ml and 15 ng/ml, respectively, as previously described (13). Visualized EP (VEP) was defined by a pregnancy accompanied by sonographic visualization of an extrauterine gestational sac (including any heterotopic gestations). Treated persistent pregnancy of unknown location (TPPUL) was defined by persistent abnormally increasing hcg titers without sonographic visualization, which were treated with methotrexate (17). Clinical pregnancy was defined based on observed fetal heart motion during sonographic examination and multiple pregnancy was based on the maximum number of fetal hearts. Ongoing pregnancy was defined as viable fetal heart motion at approximately 10 weeks' gestation, whereas spontaneous abortions were clinical pregnancies that did not achieve ongoing pregnancy. Fisher's exact test was used to compare nominal variables. After applying the Shapiro-Wilk test for normality, the Wilcoxon test was used to compare numeric variables if significant deviation from the normal distribution was observed. P values less than.05 were considered significant. The JMP version 5.01 (SAS Institute, Inc.) was used for these statistical analyses. The JMP 7.02 (SAS Institute, Inc.) was used to examine risk ratios. Institutional Review Board approval was obtained for this retrospective study. RESULTS There were 1,460 fresh autologous blastocyst transfers and 690 autologous transfers of blastocysts derived from thawed bipronuclear oocytes in the study period. The characteristics of these cycles are described in Table 1. When compared with those in the fresh transfer group, women in the PTEC group were significantly older at ET, older at oocyte retrieval, and more likely to be diagnosed with diminished ovarian reserve. No significant differences were observed in body mass index (BMI), the incidence of tubal factor, VOL. 98 NO. 6 / DECEMBER
3 ORIGINAL ARTICLE: EARLY PREGNANCY TABLE 1 Demographics and potential confounders in the two study groups. Fresh transfer PTEC P value Blastocyst transfers 1, Age at transfer (y) a a.0001 Age at retrieval (y) a a.0087 Age range at retrieval (y) Body mass index (kg/m 2 ) a a.7447 Tubal factor diagnosis (%) 320 (21.9) 161 (23.3).4714 Endometriosis (%) 74 (5.1) 42 (6.1).3575 Diminished ovarian reserve (%) 443 (30.3) 275 (39.9) <.0001 Unexplained infertility (%) 89 (6.1) 56 (8.1).0969 Tobacco use (%) 240 (16.9) 108 (16.7) Blastocysts transferred a a.5822 Note: Values are mean SD, range, or frequency (percentage). PTEC ¼ post-thaw extended culture. a Numeric variable not normally distributed per Shapiro-Wilk test (P<.0001). unexplained infertility, tobacco use, or the number of blastocysts transferred. Embryo morphology is compared in Table 2. An overall c 2 test found that ET day was not independent of the type of cycle (fresh vs. PTEC) (P<.0001). Compared with fresh transfers, the PTEC transfers were more likely to occur on day 6 or day 7 and less likely on day 5. Significantly larger mean ICM was observed for the fresh transfers on day 5 and day 6. Significantly greater mean embryo diameter and mean trophectoderm cell count were observed for the fresh transfers on day 5. All significant differences in blastocyst morphology favored the fresh transfer group. Outcomes are described in Table 3. There were significant differences in the rates of pregnancy, implantation, ongoing pregnancy, TPPUL, and VEP, but not in the rates of multiple pregnancy or spontaneous abortion. Pregnancies resulting from fresh autologous blastocyst transfers were significantly more likely to result in TPPUL or VEP when compared with those resulting from autologous PTEC. Among pregnant patients without tubal factor diagnosis, the incidence of TPPUL was 2.5% (18/725) in fresh cycles and 0.2% (1/433) in the PTEC group (P¼.0029). Among pregnant patients with tubal factor diagnosis, these rates were 2.7% (5/ 184) and 0.7% (1/147), respectively (P¼.2321). Among pregnant patients without tubal factor diagnosis, the incidence of VEP was 1.9% (14/725) in fresh autologous cycles, and 0 (0/433) in PTEC cycles (P¼.0016). Among pregnant patients with tubal factor diagnosis, there were no VEPs. DISCUSSION These findings corroborate the conclusion of Clayton et al. (5) that high implantation potential is protective against EP. Autologous PTEC cycles have had reported implantation rates of 67% and 71% in prospective studies (13, 14) in first-time IVF patients <41 years of age and the implantation rate after autologous PTEC is comparable to that of fresh oocyte donation cycles when both methods use oocytes from young patients (12). In the present study, which was not restricted on patient age or history, the implantation rate in PTEC cycles was 51.2%, which significantly exceeded the 31.8% implantation rate in the fresh cycles, despite numerous significantly superior morphological embryo parameters in the fresh transfer group. The PTEC allows 4 5 days to confirm resumed TABLE 2 Embryology parameters according to the day of blastocyst transfer. Fresh transfer PTEC P value Day 5 transfers (%) 785 (53.8) 219 (31.7) <.0001 Mean ICM area, day 5 (mm 2 ) 4,582 1,228 4,309 1, Mean embryo diameter, day 5 (mm) Mean trophectoderm cells, day Day 6 transfers 663 (45.4) 433 (62.8) <.0001 Mean ICM area, day 6 (mm 2 ) 4,221 1,510 3,982 1, Mean embryo diameter, day 6 (mm) Mean trophectoderm cells, day Day 7 transfers 12 (0.8) 38 (5.5) <.0001 Mean ICM area, day 7 (mm 2 ) 3,441 1,173 3,247 1, Mean embryo diameter, day 7 (mm) Mean trophectoderm cells, day Note: Values are mean SD or frequency (percentage). ICM ¼ inner cell mass; PTEC ¼ post-thaw extended culture VOL. 98 NO. 6 / DECEMBER 2012
4 Fertility and Sterility TABLE 3 Outcomes in the two study groups. Fresh transfer PTEC P value Relative risk (95% CI) Pregnancies Pregnancy rate (%) <.0001 TPPULs 23 2 TPPUL/pregnancy (%) ( ) Visualized ectopic pregnancies (VEP) 14 0 VEP/pregnancy (%) Undefined Clinical pregnancies Fetal hearts Implantation rate 31.8% 51.2%.0001 Multiple pregnancies Multiple pregnancy rate 38.1% 40.4%.4521 Spontaneous abortions Spontaneous abortion rate 7.2% 8.6%.4244 Ongoing pregnancies Ongoing pregnancy rate 39.9% 61.6%.0001 Note: PTEC ¼ post-thaw extended culture; TPPUL ¼ treated persistent pregnancy of unknown location. development to the blastocyst stage. This confirmed development is a more stringent criterion than the usual practice of using only immediate post-thaw survival alone, because many embryos that appear to survive thaw cease development afterward (18, 19). By transferring a developing embryo into a uterine environment that is not compromised by ovarian stimulation, PTEC achieves conditions that approximate the fresh oocyte donation cycle. These findings also support the conclusions of Ishihara et al. (11) who compared fresh and frozen-thawed ET cycles in a national registry study and concluded a negative effect of ovarian stimulation on endometrial receptivity was reflected by increased EP rates. However, another study (20) found no significant difference in ectopic rates between fresh and thawed blastocyst transfer. There were some potential confounders in this retrospective cohort study. Despite the fresh transfer group being associated with some factors that would suggest greater implantation potential (slightly younger, less likely to be diagnosed with diminished ovarian reserve, more day 5 blastocysts, and superior embryo morphology on day 5 and day 6), that group was still associated with greater rates of VEP and TPPUL and lower rates of pregnancy, implantation, and ongoing pregnancy. The greater rates of pregnancy, implantation, and ongoing pregnancy in the PTEC group have been previously attributed to superior endometrial receptivity, absent the effects of ovarian stimulation (13). The incidence of tubal factor diagnosis did not differ significantly between the two groups, and little evidence was found of a relationship between tubal factor diagnosis and EP in these results. Limitations of this study include its retrospective nature, its modest size relative to registry studies, and its use of less common methodologies. The degree of reduction in EP risk through frozen-thawed ET relative to fresh transfer may be protocol-specific. The methodology in the present study, involving post-thaw extended culture after routine use of GnRH antagonist cycles, ICSI insemination, and alternative triggering is not the current routine at most centers, and the rates of EP observed here might have been influenced by these protocol choices. The high implantation potential that is protective against EP (5) requires favorable endometrial receptivity and endometrial receptivity can be compromised by ovarian stimulation (13). Previous reports have associated frozen-thawed ET with reduced risk of EP when compared to fresh ET (11, 21). The rates of EP with frozen-thawed ET in the present study were nominally lower than in those prior studies (0.3% for TPPULs and 0 for VEPs in the present study, compared to 0.8% [11] and 1.2% [21], each for EP ). It appears that the combination of embryos with high implantation potential and a more receptive uterine environment, unimpaired by ovarian stimulation, is conducive to low risk of EP. REFERENCES 1. Farquhar CM. Ectopic pregnancy. Lancet 2005;366: Revel A, Ophir, Koler M, Achache H, Prus D. Changing etiology of tubal pregnancy following IVF. Hum Reprod 2008;23: Shaw JL, Dey SK, Critchley HO, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update 2010;16: Marcus SF, Brinsden PR. Analysis of the incidence and risk factors associated with ectopic pregnancy following in-vitro fertilization and embryo transfer. Hum Reprod 1995;10: Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol 2006;107: Fernandez H, Coste J, Job-Spira N. Controlled ovarian hyperstimulation as a risk factor for ectopic pregnancy. Obstet Gynecol 1991;78: Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007;15: Lesny P, Killick SR. The junctional zone of the uterus and its contractions. BJOG 2004;111: Paltieli Y, Eibschitz I, Ziskind G, Ohel G, Silbermann M, Weichselbaum A. High progesterone levels and ciliary dysfunction a possible cause of ectopic pregnancy. J Assist Reprod Genet 2000;17: Weigert M, Gruber D, Pernicka E, Bauer P, Feichtinger W. Previous tubal ectopic pregnancy raises the incidence of repeated ectopic pregnancies in VOL. 98 NO. 6 / DECEMBER
5 ORIGINAL ARTICLE: EARLY PREGNANCY in vitro fertilization-embryo transfer patients. J Assist Reprod Genet 2009; 26: Ishihara O, Kuwahara A, Saitoh H. Frozen-thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan. Fertil Steril 2011;95: Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Similar ongoing pregnancy rates after blastocyst transfer in fresh donor cycles and autologous cycles using cryopreserved bipronuclear oocytes suggest similar viability of transferred blastocysts. Fertil Steril 2010;93: Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozenthawed embryo transfer in normal responders. Fertil Steril 2011;96: Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozenthawed embryo transfers in high responders. Fertil Steril 2011;96: Sills ES, McLoughlin LJ, Genton MG, Walsh DJ, Coull GD, Walsh AP. Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer. J Ovarian Res 2008;1: Isachenko V, Todorov P, Dimitrov Y, Isachenko E. Integrity rate of pronuclei after cryopreservation of pronuclear-zygotes as a criteria for subsequent embryo development and pregnancy. Hum Reprod 2008;23: Barnhart K, van Mello NM, Bourne T, Kirk E, van Calster B, et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril 2011;95: Yamanaka M, Hashimoto S, Amo A, Ito-Sasaki T, Abe H, Morimoto Y. Developmental assessment of human vitrified-warmed blastocysts based on oxygen consumption. Hum Reprod 2011;26: Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Embryo cryopreservation rescues cycles with premature luteinization. Fertil Steril 2010;93: Jun SH, Milki AA. Ectopic pregnancy rates with frozen compared with fresh blastocyst transfer. Fertil Steril 2007;88: Ng EH, Yeung WS, So WW, Ho PC. An analysis of ectopic pregnancies following in vitro fertilisation treatment in a 10-year period. J Obstet Gynaecol 1998;18: VOL. 98 NO. 6 / DECEMBER 2012
A Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationUniversal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.
Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationSample size a Main finding b Main limitations
1 Table 1. Available studies on the relation between endometriosis and miscarriage (1995-2015). Study (citation) Country Study period Study design Sample size a Main finding b Main limitations Matoras
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationBlastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study
FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationMedicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study
Observational Study Medicine Combined analysis of endometrial thickness and pattern in predicting clinical outcomes of frozen embryo transfer cycles with morphological good-quality blastocyst A retrospective
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationHow to make the best use of the natural cycle for frozen-thawed embryo transfer?
How to make the best use of the natural cycle for frozen-thawed embryo transfer? Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Kasum M., Kurdija K., Orešković S., Čehić E., Pavičić-Baldani D., Škrgatić L. (2016) Combined ovulation triggering with GnRH agonist and hcg in IVF patients. Gynecological
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationThe effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles
Original Article Obstet Gynecol Sci 2014;57(4):291-296 http://dx.doi.org/10.5468/ogs.2014.57.4.291 pissn 2287-8572 eissn 2287-8580 The effect of luteal phase progesterone supplementation on natural frozen-thawed
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationDr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management
Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART
More information(a) Departamento de Ginecologia, Universidade Federal de São Paulo. (b) Centro de Reprodução Humana Fertivitro, São Paulo, Brazil.
Human Reproduction Center São Paulo Brasil Aline de Cássia Azevedo (a,b) ; Fernanda Coimbra Miyasato (b) ; Litsuko S. Fujihara (b), Maria Cecília R.M. Albuquerque (b), Ticiana V. Oliveira (b), Luiz Eduardo
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationBumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.
a. Date of notification: b. Name of reporting site: c.name of doctor in charge: AI : FEMALE PATIENT DETAILS & DEMOGRAPHICS (Instruction: if Mykad is not available, please complete Old IC or other ID document
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationHold On To Your Dreams
Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationBlastocyst culture and transfer increases the efficiency of oocyte donation
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Blastocyst culture
More informationOVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).
OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationAre all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?
Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationCitation for published version (APA): Shapiro, B. S. (2008). Optimal blastocyst transfer : the embryo and the endometrium
UvA-DARE (Digital Academic Repository) Optimal blastocyst transfer : the embryo and the endometrium Shapiro, B.S. Link to publication Citation for published version (APA): Shapiro, B. S. (2008). Optimal
More informationOriginal Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization
Original Article Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hcg by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a
More informationOvarian hyperstimulation syndrome (OHSS)
Ovarian hyperstimulation syndrome (OHSS) OHSS OHSS: exaggerated response to gonadotropins and hcg Characterized by: ovarian enlargement increased vascular permeability fluid accumulation in abdomen Associated
More informationPresident : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman ICOG. Founder Trustee Women s Empowerment Foundation
Founder President: The PCOS Society, India Honorary Fellow of the Royal College of Obst.& Gyn. Prof.Duru Shah President : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationHow to make the best use of the natural cycle for frozen-thawed embryo transfer?
How to make the best use of the natural cycle for frozen-thawed embryo transfer? Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationSerum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316
More informationMinimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology
Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication
More informationSpontaneous ovulation versus HCG triggering for timing natural-cycle frozen thawed embryo transfer: a randomized study
Reproductive BioMedicine Online (2011) 23, 484 489 www.sciencedirect.com www.rbmonline.com ARTICLE Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen thawed embryo transfer: a
More informationPredictive value of embryo grading for embryos with known outcomes
Predictive value of embryo grading for embryos with known outcomes Vanessa N. Weitzman, M.D., Jennifer Schnee-Riesz, M.D., Claudio Benadiva, M.D., John Nulsen, M.D., Linda Siano, M.S., and Donald Maier,
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationDuration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial
Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationTrends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction
Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical
More informationAssisted Reproductive Technology National Summary Report Belgium 2015
Assisted Reproductive Technology National Summary Report Belgium 2015 College van Geneesheren Reproductieve Geneeskunde Collège de Médecins Médecine de la Reproduction College of Physicians Reproductive
More informationSupraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationA comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nadkarni PK et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):617-621 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationDoes a woman s educational attainment influence in vitro fertilization outcomes?
Does a woman s educational attainment influence in vitro fertilization outcomes? The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationFRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018
FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018 OBJECTIVES Hisory Indication of freezing embryos Slow freezing versus vitrification Advantages
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationExtended embryo culture in human assisted reproduction treatments
Human Reproduction Vol.16, No.5 pp. 902 908, 2001 Extended embryo culture in human assisted reproduction treatments M.T.Langley 1,3, D.M.Marek 1, D.K.Gardner 2, K.M.Doody 1 and K.J.Doody 1 1 Center for
More informationNumber of oocytes and live births in IVF
Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationprogesterone 100mg vaginal tablets (Lutigest ) SMC No. (1185/16) Ferring Pharmaceuticals Ltd
progesterone 100mg vaginal tablets (Lutigest ) SMC No. (1185/16) Ferring Pharmaceuticals Ltd 09 September 2016 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationEndometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study
Reproductive BioMedicine Online (2010) 21, 50 55 www.sciencedirect.com www.rbmonline.com ARTICLE Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot
More informationA multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of
A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group
More informationIn vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT
Int J Reprod BioMed Vol. 15. No. 12. pp: 757-762, December 2017 Original article In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day
More informationComparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers
Received: 22 October 2017 Accepted: 22 January 2018 DOI: 10.1002/rmb2.12090 ORIGINAL ARTICLE Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers
More informationPRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018
PRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018 Clinical Assessment A thorough clinical evaluation is a prerequisite for ART A thorough clinical evaluation as detailed in the female and male
More informationClinical outcomes of frozen embryo transfer cycles after freeze-all policy to prevent ovarian hyperstimulation syndrome
Original Article Obstet Gynecol Sci 2018;61(4):497-504 https://doi.org/10.5468/ogs.2018.61.4.497 pissn 2287-8572 eissn 2287-8580 Clinical outcomes of frozen embryo transfer cycles after freeze-all policy
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationMinimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort
Kato et al. Reproductive Biology and Endocrinology 2012, 10:35 RESEARCH Open Access Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre,
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationEHY Ng, WSB Yeung, PC Ho. Introduction
Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergoing controlled ovarian stimulation: prospective randomised double-blind study EHY Ng, WSB Yeung, PC Ho
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationProf. Antonio Pellicer
Improving outcomes in ART : Time-lapse technology for monitoring COS and blastocyst culture Prof. Antonio Pellicer Instituto Valenciano de Infertilidad (IVI) University of Valencia apellicer@ivi.es www.ivi.es
More informationDay 4 embryo selection is equal to Day 5 using a new embryo scoring system validated in single embryo transfers
Human Reproduction Vol.23, No.7 pp. 1505 1510, 2008 Advance Access publication on February 21, 2008 doi:10.1093/humrep/dem419 Day 4 embryo selection is equal to Day 5 using a new embryo scoring system
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationUnderstanding IVF Processes in Surrogacy
Melvin H. Thornton II MD Medical Director CT Fertility Understanding IVF Processes in Surrogacy The Basics Surrogacy involves multiple parties IVF CLINIC Egg donors screening and matching* Medical process
More informationEvaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190
More informationConsultations and Assessment Fertility Specialist consultation 180 Ultrasound scan of uterus and ovaries 100 AMH measurement 80 Semen analysis 100
We hope this price list will help you assess the cost of your consultations, investigations and treatment. It provides information about what is included in the cost and how we make a refund if your treatment
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More information